Sapacitabine the ph2 and 300 pts, took almost 4 years...max would have a heart attack on that one. They now have combined it with dacogen. Maybe it needed a little help? The ph3 will finish in Apr 2015.
Responses that I could find in 200MG 63 pts 1 CR 2 Improved blood counts
Survival under 290 days
We'll have to see.
Rory a few years ago was touting Revlmid as a threat. Never materialized except in mild mds.
SGI-110 only needed 14 pts in MDS in the ph2 and taking less than a year? Compared to 4 years for sapacitabine. I would like astx to cross over the ph2 into the ph3. Shaving off year on data.
Could that drug be sgi-110? I like how rope a dope leaves out the drug he's talking about. Now rory, you giving mixed messages, you imply you bought shares and you imply astx going lower. Which is it? Well we know if it goes up you're covered and if it goes down you covered. Only a weasel plays it that way.